YPR097W Antibody

What is YPR097W and why is it significant for antibody development?

YPR097W is a protein in Saccharomyces cerevisiae (baker's yeast) that contains a Phox homology (PX) domain and binds phosphoinositides. Recent research has identified it as playing a role in regulating the distribution of ergosterol in yeast cells, with researchers suggesting the name Lec1 (Lipid-related) for this protein . YPR097W is particularly significant for antibody development because it functions at membrane contact sites, specifically at the endoplasmic reticulum-lipid droplet contact site (LiDER) .

The protein has been detected in highly purified mitochondria in high-throughput studies and contains functional domains common to contact site proteins, including the PX domain and a predicted FFAT motif that enables interaction with VAP proteins (Scs2 and Scs22 in yeast) . Antibodies against YPR097W are valuable tools for studying membrane contact sites, lipid trafficking, and organelle interactions in yeast, providing insights into fundamental cellular processes that may be conserved across eukaryotes.

How should researchers validate the specificity of YPR097W antibodies?

Validating YPR097W antibody specificity requires a multi-faceted approach to ensure reliable experimental results. The most definitive validation method involves testing the antibody in YPR097W knockout strains, where a true specific antibody would show no signal. Additionally, researchers should compare antibody recognition patterns with the known molecular weight of YPR097W (approximately 1073 amino acids) .

For comprehensive validation, implement the following protocol:

• Western blot analysis comparing wild-type and ΔYpr097w strains

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Immunofluorescence microscopy comparing antibody localization with GFP-tagged YPR097W

• Cross-reactivity testing against related PX domain-containing proteins, particularly YKR078W which has been identified as a predicted functional partner with a similarity score of 0.819

When validating by immunofluorescence, researchers should note that YPR097W's localization pattern varies with expression level. At endogenous levels, it localizes primarily to buds and bud necks, while overexpression leads to accumulation in internal puncta that co-localize with lipid droplets at the ER interface .

What sample preparation methods are optimal for YPR097W antibody applications?

When preparing yeast samples for YPR097W antibody applications, researchers should consider the protein's dual localization patterns and membrane association characteristics. Based on reported findings, the following optimized protocol is recommended:

For immunofluorescence microscopy:

• Fix cells with 3.7% formaldehyde for 30 minutes at room temperature

• Perform spheroplasting with zymolyase to enhance antibody penetration

• Permeabilize with a gentle detergent (0.1% Triton X-100) to preserve membrane structures

• Block with 3% BSA in PBS to reduce non-specific binding

For biochemical applications like Western blotting:

• Use glass bead lysis in the presence of protease inhibitors at 4°C

• Include phosphatase inhibitors to preserve phosphoinositide binding

• Separate membrane fractions using differential centrifugation to capture different pools of YPR097W

Since YPR097W contains a PX domain that binds phosphoinositides and localizes to specific cellular compartments during different cell cycle stages, preservation of these interactions during sample preparation is critical . When studying YPR097W at endogenous levels, enhanced detection methods may be necessary as the protein can be difficult to visualize without overexpression .

How can antibodies be used to investigate YPR097W's role in membrane contact sites?

YPR097W has been identified as a protein involved in the endoplasmic reticulum-lipid droplet contact site (LiDER) . To investigate its role in these membrane contacts, researchers can employ antibodies in several advanced applications:

• Proximity Ligation Assays (PLA): Use anti-YPR097W antibodies in combination with antibodies against known ER proteins (like Scs2/Scs22) to visualize and quantify protein interactions at contact sites. This method can detect proteins within 40nm of each other, suitable for studying membrane contact sites.

• Immuno-Electron Microscopy: Apply gold-conjugated YPR097W antibodies to precisely localize the protein at the ultrastructural level, particularly at the ER-LD interface.

• Co-immunoprecipitation Studies: Use YPR097W antibodies to pull down protein complexes, followed by mass spectrometry to identify novel interaction partners at contact sites.

• Phosphoinositide Binding Assays: Combine YPR097W antibodies with liposome flotation assays to investigate how phosphoinositide binding (particularly PI3P) affects YPR097W's localization and function at contact sites .

Research has shown that YPR097W contains a PX domain that interacts with anionic lipids including PI3P and a predicted FFAT motif that enables interaction with VAP proteins on the ER . These structural features suggest YPR097W may serve as a tether between organelles, which can be further investigated using antibody-based approaches combined with lipid manipulation techniques.

What are the challenges in detecting cell cycle-dependent changes in YPR097W localization?

Detecting cell cycle-dependent changes in YPR097W localization presents several technical challenges due to its dynamic distribution patterns. Research has shown that YPR097W's localization is affected by the cell cycle, with primary localization at buds and bud necks at endogenous expression levels, but showing different patterns when overexpressed .

Key challenges and methodological solutions include:

• Low Signal at Endogenous Levels: YPR097W is difficult to detect at endogenous levels.

  • Solution: Use signal amplification techniques such as tyramide signal amplification (TSA) or quantum dot-conjugated secondary antibodies

• Distinguishing Cell Cycle Stages:

  • Solution: Combine YPR097W antibody staining with cell cycle markers (e.g., Sic1 for G1, Clb2 for G2/M) in dual-immunofluorescence experiments

• Capturing Transient Localizations:

  • Solution: Employ synchronized cultures using α-factor arrest and release, followed by time-course fixation and immunostaining

• Quantifying Distribution Changes:

  • Solution: Use high-content imaging systems with automated analysis to measure YPR097W intensity at different cellular locations across cell cycle stages

A recommended experimental approach is to synchronize yeast cultures, collect samples at defined intervals (every 15 minutes for 3 hours), perform dual immunofluorescence for YPR097W and cell cycle markers, and quantify localization patterns using automated image analysis. This approach can reveal how YPR097W redistributes during cell division and help understand its functional significance in cell cycle-dependent processes.

How can researchers distinguish between YPR097W and its functional partners using antibodies?

YPR097W shares structural similarities with several predicted functional partners, particularly YKR078W (similarity score 0.819), which also contains a PX domain and binds phosphatidylinositol 3-phosphate . Distinguishing between these proteins requires carefully designed antibody-based approaches:

• Epitope Selection for Antibody Generation:

  • Target unique regions outside the conserved PX domain

  • Perform sequence alignment between YPR097W and its partners to identify divergent regions

  • Design peptide antigens from these unique regions for antibody production

• Validation Strategies:

  • Test antibodies on knockout strains for each protein

  • Perform Western blots on strains overexpressing each protein individually

  • Use recombinant proteins for competitive binding assays

• Dual-Labeling Approaches:

  • Employ double immunofluorescence with antibodies against YPR097W and its partners

  • Use fluorescence resonance energy transfer (FRET) to study potential interactions

The following table summarizes key distinguishing features between YPR097W and its closest functional partners:

When designing experiments to distinguish between these proteins, researchers should combine antibody specificity with localization patterns and functional assays to ensure accurate identification and characterization.

What advanced methodologies can be used to study YPR097W's role in lipid regulation?

YPR097W (Lec1) has been demonstrated to play a role in regulating the distribution of ergosterol in yeast cells . To investigate this function comprehensively, researchers can employ several advanced antibody-based methodologies:

• Super-Resolution Microscopy with Immunolabeling:

  • Combine YPR097W antibodies with lipid-specific probes (e.g., filipin for ergosterol)

  • Apply techniques such as STORM or PALM to achieve nanoscale resolution of protein-lipid associations

  • Quantify co-localization at membrane contact sites

• Correlative Light and Electron Microscopy (CLEM):

  • Immunolabel YPR097W for fluorescence imaging

  • Transfer to electron microscopy to visualize membrane ultrastructure

  • Integrate data to map YPR097W localization to specific membrane domains

• Proximity-Dependent Biotinylation (BioID/TurboID):

  • Generate fusion proteins of YPR097W with biotin ligases

  • Use antibodies to verify expression and localization

  • Identify proximal proteins involved in lipid regulation

• Lipidomic Analysis Following Immunoprecipitation:

  • Immunoprecipitate YPR097W-containing complexes

  • Analyze associated lipids by mass spectrometry

  • Determine lipid binding preferences and potential transfer activities

When designing these experiments, researchers should consider that YPR097W's PX domain interacts with phosphatidylinositol 3-phosphate , which may influence its association with lipid droplets and the endoplasmic reticulum. Additionally, the protein's localization varies with expression level and cell cycle stage , necessitating careful experimental timing and quantification.

How can biophysics-informed models guide the development of specific antibodies against YPR097W?

Recent advances in computational modeling can significantly enhance the development of highly specific antibodies against YPR097W. Drawing from principles outlined in research on antibody specificity , researchers can implement biophysics-informed approaches to design antibodies that precisely distinguish YPR097W from related proteins like YKR078W.

The methodology involves:

• Epitope Mapping and Selection:

  • Perform computational analysis of YPR097W's structure to identify surface-exposed regions unique to this protein

  • Prioritize epitopes distant from the conserved PX domain to avoid cross-reactivity

  • Use molecular dynamics simulations to assess epitope accessibility

• Machine Learning Integration:

  • Train models on existing antibody-antigen interactions

  • Predict binding affinities and cross-reactivity profiles

  • Identify sequence modifications that enhance specificity

• Experimental Validation Pipeline:

  • Generate candidate antibodies against predicted epitopes

  • Test binding to recombinant YPR097W and related proteins

  • Perform selection experiments with phage display to identify optimal binders

• Specificity Enhancement:

  • Apply the approach described in current research where "antibody variants not present in the initial library that are specific to a given combination of ligands" can be generated

  • Optimize for discrimination between YPR097W and closely related proteins

This approach aligns with recent research demonstrating that "biophysics-informed models can be employed to design novel antibody sequences with predefined binding profiles" that can be "either cross-specific, allowing interaction with several distinct ligands, or specific, enabling interaction with a single ligand while excluding others" . By applying these principles to YPR097W antibody development, researchers can create tools with unprecedented specificity for studying this protein's unique functions.

Why might YPR097W antibody signals vary between different subcellular fractions?

Researchers often observe variable YPR097W antibody signals across different subcellular fractions, a phenomenon that reflects the protein's complex localization pattern. Based on published findings, YPR097W exhibits dual localization: it appears primarily at buds and bud necks at endogenous expression levels, while also forming internal puncta that co-localize with lipid droplets at the endoplasmic reticulum interface when overexpressed .

Several factors contribute to this variability:

• Expression Level Dependence:

  • At endogenous levels, YPR097W is difficult to detect and shows primarily bud/bud neck localization

  • Under moderate overexpression (ADH1 promoter), approximately 60% of cells show cytosolic distribution

  • Strong overexpression results in accumulation at internal puncta and lipid droplets

• Cell Cycle Effects:

  • YPR097W localization is affected by cell cycle stage

  • This results in heterogeneous populations exhibiting different localization patterns

• Membrane Association Dynamics:

  • As a protein that contains lipid-binding domains (PX domain) and interacts with membrane structures, YPR097W may distribute differently during subcellular fractionation procedures

  • The strength of these associations may vary with experimental conditions

To address this variability, researchers should:

• Carefully control cell synchronization when preparing samples

• Use gentle fractionation techniques that preserve membrane associations

• Compare results between different antibody epitopes, as accessibility may vary between cellular compartments

• Include appropriate controls for each fraction (organelle-specific markers)

• Consider dual-labeling approaches to confirm the identity of YPR097W-positive structures

What controls are essential when studying YPR097W interactions with binding partners?

When investigating YPR097W interactions with its binding partners through antibody-based techniques, implementing rigorous controls is crucial to ensure data reliability. Based on the identified functional partners of YPR097W, including YKR078W, SEG2, VID27, TRM5, and VPS35 , the following controls should be incorporated:

• Genetic Controls:

  • Include YPR097W deletion strains in all experiments

  • Use strains with deletions of individual binding partners

  • Generate double-deletion strains to assess interdependence

• Antibody Specificity Controls:

  • Test all antibodies against recombinant purified proteins

  • Include pre-immune serum controls

  • Use peptide competition assays to confirm epitope specificity

• Co-immunoprecipitation Controls:

  • Perform reverse co-IPs (using antibodies against binding partners)

  • Include IgG control pull-downs

  • Test interaction in detergent conditions of varying stringency

  • Assess RNA/DNA-dependence with nuclease treatments

• Localization Controls:

  • Compare antibody and fluorescent protein fusion localization patterns

  • Use pharmacological disruption of organelles to confirm specificity of localization signals

  • Employ super-resolution techniques to verify true co-localization versus proximity

• Functional Validation:

  • Assess phenotypic consequences of disrupting specific interactions

  • Test the effect of domain mutations (e.g., PX domain or FFAT motif)

  • Monitor lipid distribution changes upon perturbation of interactions

A particularly important consideration when studying YPR097W interactions is its association with the eisosome protein SEG2 (similarity score 0.765) . Since both proteins show cell periphery localization patterns but likely serve different functions, careful controls are needed to distinguish specific from non-specific interactions occurring due to spatial proximity.

How can YPR097W antibodies contribute to understanding membrane contact site formation?

YPR097W (Lec1) represents an exciting target for investigating membrane contact site dynamics, particularly at the endoplasmic reticulum-lipid droplet interface (LiDER). As identified in systematic analysis of membrane contact sites in Saccharomyces cerevisiae, YPR097W both co-localized with and increased the brightness and frequency of the LiDER reporter in cells . Well-characterized antibodies against YPR097W can advance this field in several innovative ways:

• Temporal Mapping of Contact Site Assembly:

  • Use antibodies in time-course experiments during lipid droplet biogenesis

  • Combine with live-cell imaging techniques to correlate fixed and dynamic observations

  • Develop YPR097W biosensors based on antibody-derived binding domains

• Structural Organization Studies:

  • Apply YPR097W antibodies in immuno-electron microscopy to map the precise architecture of contact sites

  • Measure distances between YPR097W and other contact site components

  • Determine stoichiometry of YPR097W in contact site complexes

• Regulatory Mechanism Investigation:

  • Use phospho-specific antibodies to detect modifications that might regulate YPR097W's tethering function

  • Investigate how phosphoinositide binding (through the PX domain) and VAP protein interactions (through the FFAT motif) coordinate YPR097W's role at contact sites

  • Study the relationship between ergosterol distribution and contact site formation

The presence of both a PX domain that interacts with PI3P and a predicted FFAT motif in YPR097W suggests it may serve as a molecular bridge or tether between organelles . Antibodies specifically designed to recognize these domains in their native conformation would be particularly valuable for dissecting the mechanism of contact site formation and regulation.

What methodological approaches can reveal YPR097W's function in lipid metabolism pathways?

YPR097W's role in regulating ergosterol distribution positions it as a significant factor in yeast lipid metabolism. Investigating its precise function requires sophisticated methodological approaches centered around carefully validated antibodies:

• Metabolic Labeling Combined with Immunoprecipitation:

  • Pulse-chase experiments with radioactive or stable isotope-labeled lipid precursors

  • Immunoprecipitate YPR097W complexes at various timepoints

  • Analyze associated lipids to determine if YPR097W directly participates in lipid transport or modification

• Organelle-Specific Lipidomics:

  • Use YPR097W antibodies to immunoisolate specific membrane contact sites

  • Perform lipidomic analysis on these isolated fractions

  • Compare lipid profiles between wild-type and ΔYpr097w strains under various growth conditions

• Reconstitution Systems:

  • Purify YPR097W using antibody-based affinity chromatography

  • Reconstitute with artificial membrane systems

  • Measure lipid transfer or membrane tethering activities in vitro

• Genetic Interaction Analysis:

  • Create an antibody-based biosensor for YPR097W activity

  • Screen for genetic interactions with known lipid metabolism genes

  • Validate interactions through biochemical approaches

The relationship between YPR097W and its predicted functional partners suggests it may function within a larger network of proteins involved in lipid homeostasis. A comprehensive methodology would include verification of these interactions through antibody-based approaches combined with functional lipid metabolism assays.